SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001048462-13-000058
Filing Date
2013-12-05
Accepted
2013-12-05 16:45:26
Documents
1
Group Members
CHARLES E. DAVIDSONIOTA INVESTORS LLCJOSEPH M. JACOBSWEXFORD GP LLCWEXFORD SPECTRUM INVESTORS LLC

Document Format Files

Seq Description Document Type Size
1 WEXFORD CAPITAL SC13D A3 12-05-2013 formsc13da3.htm SC 13D/A 167674
  Complete submission text file 0001048462-13-000058.txt   169726
Mailing Address 411 W PUTNAM AVENUE GREENWICH CT 06830
Business Address 411 W PUTNAM AVENUE GREENWICH CT 06830 2038627000
WEXFORD CAPITAL LP (Filed by) CIK: 0001048462 (see all company filings)

IRS No.: 061442624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Subject) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81959 | Film No.: 131260284
SIC: 2834 Pharmaceutical Preparations